Eli Lilly and Company (LLY) Financial Statements (2023 and earlier)
Company Profile
| Business Address |
LILLY CORPORATE CTR INDIANAPOLIS, IN 46285 |
| State of Incorp. | IN |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in millions)Annual | Quarterly
| 9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | 12/31/2021 Q4 | 9/30/2021 Q3 | 6/30/2021 Q2 | 3/31/2021 Q1 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 2,742 | 2,737 | 2,568 | 3,909 | 3,825 | 3,271 | 3,051 | ||
| Cash and cash equivalents | 2,617 | 2,623 | 2,459 | 3,819 | 3,788 | 3,220 | 3,002 | ||
| Short-term investments | 125 | 114 | 109 | 90 | 37 | 51 | 49 | ||
| Receivables | 8,325 | 7,672 | 7,806 | 6,673 | 7,025 | 6,903 | 6,659 | ||
| Inventory, net of allowances, customer advances and progress billings | 3,831 | 3,899 | 3,893 | 3,886 | 3,907 | 3,825 | 3,661 | ||
| Inventory | 3,831 | 3,899 | 3,893 | 3,886 | 3,907 | 3,825 | 3,661 | ||
| Prepaid expense | 2,742 | 2,807 | 2,698 | 2,531 | 3,051 | 3,297 | 3,234 | ||
| Other undisclosed current assets | 1,454 | ||||||||
| Total current assets: | 17,640 | 17,115 | 16,965 | 18,452 | 17,808 | 17,296 | 16,605 | ||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 9,311 | 9,128 | 9,103 | 8,985 | 8,920 | 8,856 | 8,630 | ||
| Long-term investments and receivables | 2,575 | 2,587 | 2,727 | 3,213 | 3,351 | 3,475 | 3,232 | ||
| Long-term investments | 2,575 | 2,587 | 2,727 | 3,213 | 3,351 | 3,475 | 3,232 | ||
| Intangible assets, net (including goodwill) | 11,016 | 11,390 | 11,374 | 11,584 | 11,772 | 11,870 | 11,965 | ||
| Goodwill | 3,892 | 3,892 | 3,892 | 3,892 | 3,884 | 3,884 | 3,877 | ||
| Intangible assets, net (excluding goodwill) | 7,124 | 7,498 | 7,482 | 7,692 | 7,888 | 7,985 | 8,088 | ||
| Regulated entity, other noncurrent assets | 84 | ||||||||
| Deferred income tax assets | 2,384 | 2,372 | 2,465 | 2,489 | 2,626 | 2,675 | 2,650 | ||
| Other noncurrent assets | 4,536 | 4,472 | 4,285 | 3,710 | 3,639 | 3,756 | |||
| Other undisclosed noncurrent assets | 3,999 | ||||||||
| Total noncurrent assets: | 29,822 | 29,948 | 29,955 | 30,354 | 30,379 | 30,514 | 30,234 | ||
| TOTAL ASSETS: | 47,462 | 47,064 | 46,919 | 48,806 | 48,187 | 47,809 | 46,838 | ||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 5,023 | 5,349 | 2,725 | 3,641 | 2,607 | 3,654 | 3,081 | ||
| Accounts payable | 1,683 | 1,659 | 1,433 | 1,671 | 1,567 | 1,598 | 1,640 | ||
| Accrued liabilities | 1,670 | 1,845 | |||||||
| Employee-related liabilities | 984 | 836 | 693 | 958 | 837 | 756 | 650 | ||
| Taxes payable | 686 | 127 | 598 | 127 | 204 | 530 | 792 | ||
| Interest and dividends payable | 882 | 886 | 771 | ||||||
| Debt | 1,745 | 2,122 | 1,356 | 1,538 | 1,563 | 1,779 | 5 | ||
| Other liabilities | 1,987 | 2,004 | 2,537 | 3,028 | 2,327 | 2,625 | 2,807 | ||
| Other undisclosed current liabilities | 6,899 | 6,147 | 6,769 | 6,846 | 7,186 | 7,036 | 5,821 | ||
| Total current liabilities: | 15,653 | 15,621 | 13,386 | 15,053 | 13,682 | 15,093 | 11,714 | ||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 14,144 | 14,692 | 15,153 | 15,346 | 15,522 | 14,737 | 16,200 | ||
| Long-term debt, excluding current maturities | 14,144 | 14,692 | 15,153 | 15,346 | 15,522 | 14,737 | 16,200 | ||
| Liabilities, other than long-term debt | 7,499 | 8,092 | 8,918 | 9,252 | 11,029 | 11,316 | 11,825 | ||
| Accounts payable and accrued liabilities | 3,642 | 3,558 | 3,978 | 3,920 | 3,769 | 3,738 | 3,918 | ||
| Deferred income tax liabilities | 172 | 863 | 1,286 | 1,734 | 1,633 | 1,857 | 2,201 | ||
| Liability, pension and other postretirement and postemployment benefits | 1,833 | 1,889 | 1,940 | 1,954 | 3,879 | 3,919 | 3,970 | ||
| Other liabilities | 1,853 | 1,783 | 1,714 | 1,644 | 1,749 | 1,802 | 1,737 | ||
| Total noncurrent liabilities: | 21,643 | 22,784 | 24,071 | 24,599 | 26,551 | 26,052 | 28,025 | ||
| Total liabilities: | 37,296 | 38,404 | 37,457 | 39,651 | 40,233 | 41,146 | 39,739 | ||
| Stockholders' equity | |||||||||
| Stockholders' equity attributable to parent, including: | 10,070 | 8,545 | 9,331 | 8,979 | 7,757 | 6,444 | 6,899 | ||
| Common stock | 594 | 594 | 594 | 596 | 598 | 598 | 600 | ||
| Treasury stock, value | (51) | (51) | (51) | (53) | (53) | (53) | (53) | ||
| Additional paid in capital | 6,829 | 6,746 | 6,656 | 6,833 | 6,758 | 6,669 | 6,579 | ||
| Accumulated other comprehensive loss | (4,296) | (4,288) | (4,225) | (4,343) | (6,173) | (6,287) | (6,396) | ||
| Retained earnings | 10,007 | 8,556 | 9,369 | 8,959 | 9,639 | 8,530 | 9,181 | ||
| Other undisclosed stockholders' equity attributable to parent | (3,013) | (3,013) | (3,013) | (3,013) | (3,013) | (3,013) | (3,013) | ||
| Stockholders' equity attributable to noncontrolling interest | 96 | 115 | 131 | 176 | 197 | 219 | 201 | ||
| Total stockholders' equity: | 10,166 | 8,659 | 9,462 | 9,155 | 7,954 | 6,664 | 7,099 | ||
| TOTAL LIABILITIES AND EQUITY: | 47,462 | 47,064 | 46,919 | 48,806 | 48,187 | 47,809 | 46,838 | ||
Income Statement (P&L) ($ in millions) Annual | Quarterly
| 9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | 12/31/2021 Q4 | 9/30/2021 Q3 | 6/30/2021 Q2 | 3/31/2021 Q1 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 6,942 | 6,488 | 7,810 | 8,000 | 6,773 | 6,740 | 6,806 | |
| Cost of revenue (Cost of Goods and Services Sold) | (1,579) | (1,431) | (2,072) | (2,050) | (1,431) | (1,953) | (1,879) | |
| Gross profit: | 5,363 | 5,058 | 5,738 | 5,950 | 5,342 | 4,787 | 4,927 | |
| Operating expenses | (3,624) | (3,407) | (3,168) | (3,656) | (3,287) | (3,359) | (3,472) | |
| Operating income: | 1,739 | 1,651 | 2,570 | 2,294 | 2,055 | 1,428 | 1,455 | |
| Nonoperating income (expense) | (111) | (119) | (351) | (77) | (636) | 191 | 321 | |
| Investment income, nonoperating | 20 | 10 | 7 | 7 | 7 | 5 | 6 | |
| Net periodic defined benefits expense (reversal of expense), excluding service cost component | 92 | 94 | 93 | 73 | 73 | 71 | 73 | |
| Other nonoperating income (expense) | (19) | (24) | 59 | 17 | 20 | (15) | 29 | |
| Interest and debt expense | (82) | (81) | (85) | (405) | (87) | (88) | ||
| Income from continuing operations before equity method investments, income taxes: | 1,546 | 1,450 | 2,134 | 2,217 | 1,014 | 1,532 | 1,688 | |
| Other undisclosed income (loss) from continuing operations before income taxes | 19 | (359) | (81) | (377) | 231 | 62 | (212) | |
| Income from continuing operations before income taxes: | 1,566 | 1,091 | 2,054 | 1,840 | 1,245 | 1,594 | 1,476 | |
| Income tax expense | (114) | (138) | (151) | (114) | (135) | (204) | (121) | |
| Net income available to common stockholders, diluted: | 1,452 | 953 | 1,903 | 1,726 | 1,110 | 1,390 | 1,355 | |
Comprehensive Income ($ in millions)Annual | Quarterly
| 9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | 12/31/2021 Q4 | 9/30/2021 Q3 | 6/30/2021 Q2 | 3/31/2021 Q1 | ||
|---|---|---|---|---|---|---|---|---|
| Net income: | 1,452 | 953 | 1,903 | 1,726 | 1,110 | 1,390 | 1,355 | |
| Other comprehensive income (loss) | (8) | (62) | 118 | 1,830 | 114 | 109 | 101 | |
| Comprehensive income, net of tax, attributable to parent: | 1,444 | 890 | 2,021 | 3,556 | 1,225 | 1,499 | 1,456 | |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.